José Leal joined the Health Economics Research Centre in January 2004, having completed his MSc in Health Economics at the University of York in 2003. Since joining HERC, José has worked on several projects, including an economic evaluation of genetic testing for sudden cardiac death, an economic evaluation of MS/MS screening for Medium Chain Acyl-CoenzymeA Dehydrogenase Deficiency, elicitation of expert opinion and several cost-of-illness studies.
José has recently completed a doctoral thesis at the University of Oxford on the use of multi-parameter evidence synthesis to inform economic evaluations. His current research interests include the use of expert opinion to inform decision models, evidence synthesis frameworks in economic evaluation and individual patient level modelling.
An Intuitive Risk Communication Tool to Enhance Patient-Provider Partnership in Diabetes Consultation.
Rouyard T. et al, (2021), J Diabetes Sci Technol
Prediction of mortality and major cardiovascular complications in type 2 diabetes: External validation of UK Prospective Diabetes Study outcomes model version 2 in two European observational cohorts.
Pagano E. et al, (2020), Diabetes Obes Metab
Cost-effectiveness of mechanical thrombectomy for treatment of non-minor ischaemic stroke across Europe
CANDIO F. et al, (2020), Stroke
Health-related quality of life in people with predementia Alzheimer's disease, mild cognitive impairment or dementia measured with preference-based instruments: a systematic literature review.
Landeiro F. et al, (2020), Alzheimers Res Ther, 12
Outpatient physiotherapy versus home-based rehabilitation for patients at risk of poor outcomes after knee arthroplasty: CORKA RCT.
Barker KL. et al, (2020), Health technology assessment (Winchester, England), 24, 1 - 116